US SB5046 | 2023-2024 | 118th Congress

Status

Spectrum: Bipartisan Bill
Status: Engrossed on December 16 2024 - 50% progression
Action: 2024-12-16 - Held at the desk.
Text: Latest bill text (Engrossed) [PDF]

Summary

A bill to require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

FDA Modernization Act 3.0

Sponsors


History

DateChamberAction
2024-12-16HouseHeld at the desk.
2024-12-16HouseReceived in the House.
2024-12-13SenateMessage on Senate action sent to the House.
2024-12-12SenatePassed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7044)
2024-12-12SenateS.Amdt.3328 Amendment SA 3328 proposed by Senator Schumer for Senator Booker. (consideration: CR S7044)
2024-12-12SenateS.Amdt.3328 Amendment SA 3328 agreed to in Senate by Unanimous Consent.
2024-12-12SenateMeasure laid before Senate by unanimous consent. (consideration: CR S7044)
2024-12-12SenateSenate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
2024-09-12SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB7248 (Related) 2024-02-09 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


Bill Comments

feedback